Detailed Information

Cited 8 time in webofscience Cited 7 time in scopus
Metadata Downloads

Risk factors and molecular epidemiology of community-onset, multidrug resistance extended-spectrum beta-lactamase-producing Escherichia coli infectionsopen access

Authors
Park, SY[Park, So Yeon]Kang, CI[Kang, Cheol-In]Wi, YM[Wi, Yu Mi]Chung, DR[Chung, Doo Ryeon]Peck, KR[Peck, Kyong Ran]Lee, NY[Lee, Nam-Yong]Song, JH[Song, Jae-Hoon]
Issue Date
Jan-2017
Publisher
KOREAN ASSOC INTERNAL MEDICINE
Keywords
Drug resistance, multiple; Extended-spectrum beta-lactamase; Escherichia coli; Community-onset infection
Citation
KOREAN JOURNAL OF INTERNAL MEDICINE, v.32, no.1, pp.146 - 157
Indexed
SCIE
SCOPUS
KCI
Journal Title
KOREAN JOURNAL OF INTERNAL MEDICINE
Volume
32
Number
1
Start Page
146
End Page
157
URI
https://scholarworks.bwise.kr/skku/handle/2021.sw.skku/30557
DOI
10.3904/kjim.2015.113
ISSN
1226-3303
Abstract
Background/Aims: Although multidrug resistance (MDR) among extended-spectrum beta-lactamase-producing Escherichia coli (ESBL-EC) poses significant therapeutic challenges, little is known regarding the risk factors and epidemiology of community-onset MDR-ESBL-EC infections. We performed this study to investigate risk factors and the molecular epidemiology of community-onset MDR-ESBL-EC infections. Methods: We conducted a case-control-control study of community-onset infections. MDR-ESBL-EC was defined as ESBL-EC that demonstrated in vitro resistance to trimethoprim-sulfamethoxazole, fluoroquinolones (FQs), and gentamicin. Patients with MDR-ESBL-EC infections were designated as case patients. A control group I (CG I) patient was defined as a person whose clinical sample yielded ESBL-EC that did not meet the criteria for MDR. A control group II (CG II) patient was defined as a patient with a non-ESBL-EC infection. Results: Of 108 patients with ESBL-EC infections, 30 cases (27.8%) were due to MDR-ESBL-EC. Compared with CG I, prior use of FQs (odds ratio [OR], 3.16; 95% confidence interval [CI], 1.11 to 8.98) and immunosuppressant use (OR, 10.47; 95% CI, 1.07 to 102.57) were significantly associated with MDR-ESBL-EC. Compared with CG II, prior use of FQs (OR, 15.53; 95% CI, 2.86 to 84.27) and healthcare-associated infection (OR, 5.98; 95% CI, 2.26 to 15.86) were significantly associated with MDR-ESBL-EC. CTX-M-15 was the most common in MDR-ESBL-EC infections (59.1% [13/22]), while CTX-M-14 was the most common in non-MDR-ESBL-EC infections (41.6% [32/77]). CTX-M-15 was significantly associated with MDR-ESBL-EC (59.1% vs. 32.5%, p = 0.028). Pulsed-field gel electrophoresis showed clonal diversity of MDR-ESBL-EC isolates. Conclusions: The emergence of strains of MDR-ESBL-EC in the community poses an important new public health threat. More information on the emergence and transmission of these strains will be necessary in order to prevent their spread.
Files in This Item
There are no files associated with this item.
Appears in
Collections
Medicine > Department of Medicine > 1. Journal Articles

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Related Researcher

Researcher PECK, KYONG RAN photo

PECK, KYONG RAN
Medicine (Medicine)
Read more

Altmetrics

Total Views & Downloads

BROWSE